US FDA approves Lilly and Incyte’s Olumiant for treating certain hospitalised patients with COVID-19 Read more
Lilly issues Complete Response Letter for Sintilimab in combination with Pemetrexed and Platinum chemotherapy for NSCLC treatment Read more